Physician profile
Julia E Shauger
NPI 1083628101
$2,057.54
in general payments reported to CMS, 2019-2025
15 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.03 · 2020: $20.83 · 2021: $63.00 · 2022: $170 · 2023: $211 · 2024: $394 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061 · Travel and Lodging: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,061.28 |
| Travel and Lodging | $703.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $866.03 | 2024-2025 | |
| Stryker Corporation | $702.10 | 2022-2025 | Citrefix, Swanson, Limflow System |
| Paratek Pharmaceuticals, INC. | $121.33 | 2025 | Nuzyra |
| Paragon 28, INC. | $55.04 | 2024 | Hammertube Sterile Implant Kits |
| Lightbody Medical Technologies INC | $52.48 | 2025 | |
| Next Science LLC | $46.33 | 2024 | Xperience, Surgx, Blastx |
| Osteomed LLC | $34.34 | 2020-2021 | |
| Orthofix Medical, INC. | $33.71 | 2019-2025 | Physio-Stim |
| Amgen INC. | $32.34 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $30.24 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.25 | 2021 | |
| Melinta Therapeutics, LLC | $18.89 | 2022 | |
| Reprise Biomedical, INC. | $18.24 | 2024 | Miro3d |
| Hikma Pharmaceuticals USA | $15.09 | 2019 | |
| Bioventus LLC | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Shauger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.